Mark K. Doherty
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lung Cancer Treatments and Mutations 11
- Brain Metastases and Treatment 4
- Lung Cancer Diagnosis and Treatment 4
- Oncology 18
- Pancreatic and Hepatic Oncology Research 4
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Jennifer Jane Knox (7 shared papers)Natasha B. Leighl (7 shared papers)Ming‐Sound Tsao (3 shared papers)Frances Alice Shepherd (5 shared papers)Catherine Labbé (4 shared papers)Kevin Jao (4 shared papers)Geoffrey Liu (4 shared papers)Roizar Rosales (1 shared paper)
- Journals
- Journal of Thoracic Oncology (5 papers)Radiotherapy and Oncology (3 papers)Lung Cancer (3 papers)The Oncologist (3 papers)Annals of Oncology (2 papers)
- Partner nations
- CanadaUnited StatesIreland
In The Last Decade
Mark K. Doherty
59 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 80
- Hepatology 220
- Oncology 471
- Pulmonary and Respiratory Medicine 412
- Cancer Research 143
- Epidemiology 145
Countries citing papers authored by Mark K. Doherty
This map shows the geographic impact of Mark K. Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark K. Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark K. Doherty more than expected).
Fields of papers citing papers by Mark K. Doherty
This network shows the impact of papers produced by Mark K. Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark K. Doherty. The network helps show where Mark K. Doherty may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark K. Doherty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 232 | |
| 2 | 2017 | 181 | |
| 3 | 2004 | 78 | |
| 4 | 1989 | 62 | |
| 5 | 2016 | 60 | |
| 6 | 2011 | 49 | |
| 7 | 2018 | 46 | |
| 8 | 2017 | 44 | |
| 9 | 2015 | 34 | |
| 10 | 2017 | 32 | |
| 11 | 2020 | 29 | |
| 12 | 2022 | 27 | |
| 13 | 2015 | 25 | |
| 14 | 2016 | 25 | |
| 15 | 2019 | 22 | |
| 16 | 2021 | 22 | |
| 17 | Fat embolism syndrome following bone marrow harvesting. | 1991 | 18 |
| 18 | 2016 | 18 | |
| 19 | 2018 | 17 | |
| 20 | 2013 | 14 |
About Mark K. Doherty
Mark K. Doherty is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Obstetrics and Gynecology and Hepatology, having authored 61 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Brain Metastases and Treatment (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Esophageal and GI Pathology (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Hepatology (220 citations), Oncology (471 citations), Pulmonary and Respiratory Medicine (412 citations), Cancer Research (143 citations) and Epidemiology (145 citations). Mark K. Doherty has collaborated with scholars based in Canada, United States and Ireland. Frequent co-authors include Jennifer Jane Knox, Natasha B. Leighl, Ming‐Sound Tsao, Frances Alice Shepherd, Catherine Labbé, Kevin Jao, Geoffrey Liu, Roizar Rosales, James D. Brierley and Sandra Elisabeth Fischer. Their work appears in journals such as Journal of Thoracic Oncology, Radiotherapy and Oncology, Lung Cancer, The Oncologist and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.